Bioinformatics Services Market Size Worth US$ 8,442.9 Million by 2030 | Persistence Market Research

Global bioinformatics services thrive across industries like bioremediation, forensics, and agriculture, buoyed by growing financial support from private and public sectors


New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Market Size & Overview:

Market participants in the global bioinformatics services sector primarily provide services such as data analysis, gene expression, sequencing, database administration, and discovery. These solutions find applications across various specialized domains within healthcare and life sciences, including plant science, medical research, forensics, and more.

Anticipated to grow at a compound annual growth rate (CAGR) of 14.7%, the global bioinformatics services market is projected to expand from USD 3,227.8 million in 2023 to USD 8,442.9 million in 2030.

Demand Analysis

The global bioinformatics services market is experiencing robust growth, propelled by the widespread adoption of bioinformatics services in diverse industries such as bioremediation, forensics, consumer products, food and beverages, and agriculture. This expansion is further fueled by substantial financial support from both private and public sources. The scientific community is increasingly favoring bioinformatics services due to the development of advanced methods for predicting protein sequences and gene function. The integration of bioinformatics systems in proteomics and genomics is opening up new opportunities for service providers, allowing them to meet the rising demand with precise and cost-effective solutions. Looking ahead, the market is expected to maintain its momentum, driven by the persistent need for accurate and high-quality data analysis tools.

Request for SAMPLE copy of report: https://www.persistencemarketresearch.com/samples/29629

Market Scope: 

Report Coverage Details 
Market Revenue 2023USD 3,227.8 million
Estimated Revenue 2030USD 8,442.9 million
Growth Rate - CAGR 14.7% 
Forecast Period 2023-2030
No. of Pages 210 Pages 
Market Segmentation 
  • Product
  • End User
  • Region
Regions Covered 
  • North America
  • Europe
  • Latin America
  • East Asia
  • The Middle East & Africa
  • South Asia & Pacific
Key Companies Profiled 
  • Illumina, Inc.
  • Thermo Fisher Scientific
  • Strand Life Sciences, Inc.
  • CD Genomics
  • Biomax Informatics AG
  • DNANEXUS, INC.
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Gene Codes Corporation
  • BGI Group
  • Gene Code Corporation
  • PerkinElmer Inc.
  • Premier Biosoft
  • Biomatters Geneious
  • Creative-Biolabs

In a nutshell, the Persistence Market Research report is a must-read for start-ups, industry players, investors, researchers, consultants, business strategists, and all those who are looking to understand this industry. Get a glance at the report at: https://www.persistencemarketresearch.com/market-research/bioinformatics-services-market.asp

Market Growth Drivers:

Diverse Industry Applications: The increasing adoption of bioinformatics services across various industries, such as bioremediation, forensics, consumer products, food and beverages, and agriculture, is a key driver. The versatility of bioinformatics in addressing different industry needs enhances its overall market demand.

Financial Support: Substantial financial backing from both private and public sources provides a significant boost to the bioinformatics services market. Funding supports research and development activities, technological advancements, and the expansion of service offerings.

Technological Advancements: Ongoing developments in bioinformatics, including improved methods for predicting protein sequences and gene function, contribute to the market's growth. Enhanced tools and methodologies attract users seeking more sophisticated and accurate solutions for data analysis and interpretation.

Popularity in Scientific Research: The increasing popularity of bioinformatics services in the scientific community drives market growth. Researchers and scientists recognize the value of bioinformatics in handling complex biological data, leading to a higher adoption rate in various scientific endeavors.

Integration in Proteomics and Genomics: The utilization of integrated bioinformatics systems in proteomics and genomics expands opportunities for service providers. This integration allows for more comprehensive and holistic analyses, meeting the demands for precise and cost-effective solutions in these fields.

Market Restraints:

Data Security and Privacy Concerns: The handling of sensitive biological and genetic data raises concerns about privacy and security. Stringent regulations and ethical considerations may limit the sharing and utilization of certain datasets, impacting the seamless flow of information crucial for bioinformatics services.

High Initial Costs: The implementation of advanced bioinformatics services often involves significant upfront costs. This can be a barrier, especially for smaller organizations and research institutions with limited budgets, hindering their ability to adopt these services.

Lack of Standardization: The absence of standardized protocols and formats for biological data can complicate interoperability between different bioinformatics tools and platforms. This lack of standardization may hinder the seamless exchange of information and collaborative efforts within the scientific community.

Technical Complexity: Bioinformatics services often involve complex algorithms, computational models, and analytical tools. The technical complexity of these services may pose a challenge for users who lack specialized skills, leading to potential barriers in widespread adoption.

Limited Awareness and Education: Some industries and researchers may not be fully aware of the capabilities and benefits of bioinformatics services. Limited educational initiatives and awareness programs may result in underutilization of these services in certain sectors.

Opportunities:

Personalized Medicine and Healthcare: The increasing focus on personalized medicine, which tailors medical treatment to individual characteristics, offers significant opportunities for bioinformatics services. Analyzing genetic and molecular data can provide insights for more personalized and effective healthcare interventions.

Drug Discovery and Development: Bioinformatics plays a crucial role in accelerating drug discovery and development processes. The integration of computational biology, genomics, and other bioinformatics tools enhances target identification, validation, and optimization, providing opportunities for collaboration between bioinformatics service providers and pharmaceutical companies.

Precision Agriculture: In the field of agriculture, bioinformatics services can contribute to precision farming by analyzing genomic data to optimize crop yields, manage diseases, and enhance overall agricultural productivity. This presents opportunities for bioinformatics service providers to support the agricultural sector.

Biotechnology and Synthetic Biology: The growth of biotechnology and synthetic biology relies on advanced computational tools for designing and analyzing biological systems. Bioinformatics services can contribute to the optimization and engineering of biological processes, creating opportunities for partnerships and service offerings in these fields.

Integration with Artificial Intelligence (AI) and Machine Learning (ML): The combination of bioinformatics with AI and ML presents exciting opportunities. These technologies can enhance the analysis of complex biological data, identify patterns, and provide more accurate predictions, leading to advancements in diagnostics, drug discovery, and other life sciences applications.

Key Recent Developments

Personalized Medicine and Genomics: Bioinformatics services have been increasingly utilized in personalized medicine initiatives. The analysis of genomic data for personalized treatment plans and drug discovery has been a major focus.

AI and Machine Learning Integration: The incorporation of artificial intelligence (AI) and machine learning (ML) in bioinformatics tools and services has been on the rise. These technologies enhance the analysis of complex biological data, leading to more accurate predictions and insights.

Cloud-Based Solutions: Cloud-based bioinformatics solutions have gained popularity due to their scalability, accessibility, and cost-effectiveness. Many service providers have been offering cloud-based platforms for data storage, analysis, and collaboration.

Drug Discovery and Development: Bioinformatics plays a crucial role in drug discovery by facilitating the analysis of biological data to identify potential drug candidates and understand their mechanisms of action.

Collaborations and Partnerships: Increased collaborations between bioinformatics service providers, pharmaceutical companies, and research institutions have been observed. These partnerships aim to leverage combined expertise and resources for more comprehensive data analysis.

COVID-19 Pandemic Impact: The COVID-19 pandemic has accelerated the use of bioinformatics in understanding the virus's genomics, tracking mutations, and developing diagnostic tools and vaccines. Bioinformatics services have played a vital role in analyzing large-scale genomic data related to the virus.

Data Security and Privacy: With the increasing amount of sensitive biological and genomic data being generated, there has been a growing emphasis on data security and privacy in bioinformatics services.

Emerging Technologies: The incorporation of emerging technologies, such as blockchain, for secure and transparent management of genomic data, has been explored.

Some of the market players:

  • Illumina, Inc.: Illumina is a leading company in genomics and DNA sequencing. They provide a range of products and services, including sequencing platforms, reagents, and bioinformatics solutions for genetic analysis.
  • Thermo Fisher Scientific: Thermo Fisher Scientific is a global company offering scientific research services and products. In genomics, they provide solutions for DNA and RNA analysis, including sequencing technologies, reagents, and bioinformatics tools.
  • Strand Life Sciences, Inc.: Strand Life Sciences is a bioinformatics company that focuses on delivering integrated genomic solutions for research and clinical applications. Their offerings include data analysis, interpretation, and visualization tools.
  • CD Genomics: CD Genomics is a biotechnology company providing services in genomics, including DNA sequencing, RNA sequencing, and bioinformatics analysis. They cater to both research and clinical applications.
  • Biomax Informatics AG: Biomax Informatics AG specializes in bioinformatics and data management solutions. They provide software and services for the integration and analysis of biological and clinical data.
  • DNANEXUS, INC.: DNANEXUS is a cloud-based genomics platform that offers tools for managing, analyzing, and interpreting genomic data. Their platform facilitates collaboration and data sharing in genomic research.
  • Agilent Technologies, Inc.: Agilent Technologies is a global company providing scientific instruments, reagents, software, and services. In genomics, they offer solutions for DNA and RNA analysis, including microarrays and next-generation sequencing technologies.
  • QIAGEN N.V.: QIAGEN is a biotechnology company offering sample and assay technologies for molecular diagnostics, applied testing, and academic research. They provide bioinformatics solutions for the analysis of genomic data.
  • Gene Codes Corporation: Gene Codes Corporation specializes in bioinformatics software solutions for DNA sequence analysis. Their software is used for tasks such as sequence assembly, alignment, and mutation detection.
  • BGI Group: BGI Group is a genomics and biotechnology company that offers a wide range of services, including DNA sequencing, bioinformatics, and genetic testing. They are known for large-scale genomic projects.
  • PerkinElmer Inc.: PerkinElmer is a global company providing solutions for diagnostics, life sciences, and applied services. In genomics, they offer tools for DNA and RNA analysis, including sequencing technologies and associated reagents.

Bioinformatics Services Market Categorization

By Service Type

Drug Development

Molecular Medicine

Microbial Genome Applications

Gene Therapy

Veterinary Science

Forensic Analysis

Bioinformatics Services Market by Application

Sequencing

Data Storage and Managemen

Data Analysis

Drug Discovery

Bioinformatics Services Market by End User

Academics and Research Centers

Pharmaceutical and Biotechnology Industries

Forensics Laboratories

Bioinformatics Services Market by Region

North America

Latin America

Europe

Asia Pacific

Middle East & Africa (MEA)

About Persistence Market Research: 

Business intelligence is the foundation of every business model employed by Persistence Market Research. Multi-dimensional sources are being put to work, which include big data, customer experience analytics, and real-time data collection. Thus, working on “micros” by Persistence Market Research helps companies overcome their “macro” business challenges. 

Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies’/clients’ shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part. 

Contact 

Persistence Market Research 

Teerth Technospace, Unit B-704 

Survey Number - 103, Baner 

Mumbai Bangalore Highway 

Pune 411045 India 

Email: sales@persistencemarketresearch.com 

Web: https://www.persistencemarketresearch.com